Decyl(triphenyl)phosphonium

Decyl(triphenyl)phosphonium (DTPP) is the organophosphorus cation with the formula C10H21P(C6H5)3+. It is a lipophilic quaternary phosphonium cation. It forms the basis for many mitochondrial-targeted drugs, including MitoQ, MitoE, and SkQ. It binds to the mitochondrial matrix by insertion into the inner membrane.[1][2] DTPP itself can cause mitochondrial swelling in kidney tissue, an action possibly related to increased membrane permeability.[3]

Decyl(triphenyl)phosphonium
Names
IUPAC name
Dodecyl(triphenyl)phosphanium
Other names
Dodecyltriphenylphosphonium, C12TPP(+), DTPP
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
UNII
Properties
C30H40P+
Molar mass 431.623 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

References

  1. Murphy, MP (2008). "Targeting lipophilic cations to mitochondria". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1777 (7–8): 1028–31. doi:10.1016/j.bbabio.2008.03.029. PMID 18439417.
  2. Leo, S; Szabadkai, G; Rizzuto, R (December 2008). "The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle". Annals of the New York Academy of Sciences. 1147: 264–74. doi:10.1196/annals.1427.019. PMC 2676430. PMID 19076448.
  3. Gottwald, EM; Duss, M; Bugarski, M; Haenni, D; Schuh, CD; Landau, EM; Hall, AM (April 2018). "The targeted anti-oxidant MitoQ causes mitochondrial swelling in kidney tissue. It and depolarization in kidney tissue". Physiological Reports. 6 (7): e13667. doi:10.14814/phy2.13667. PMC 5880956. PMID 29611340.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.